Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52

Modern Rheumatology

Volumn 26, Issue 3, 2016, Pages 403-409

  Yamasaki, Yoshioki ^a   Satoh, Minoru ^b,c   Mizushima, Machiko ^a   Okazaki, Takahiro ^a   Nagafuchi, Hiroko ^a   Ooka, Seido ^a   Shibata, Tomohiko ^d   Nakano, Hiromasa ^a   Ogawa, Hitoshi ^a   Azuma, Kohei ^a   Maeda, Akihiko ^a   Tonooka, Kumiko ^a   Ito, Hiroshi ^a   Takakuwa, Yukiko ^a   Inoue, Makoto ^a   Mitomi, Hirofumi ^a   Kiyokawa, Tomofumi ^a   Tsuchida, Kosei ^a   Matsushita, Hiromi ^a   Mikage, Hidenori ^a   Murakami, Yoshihiko ^a   Chan, Jason Y F ^c   Ozaki, Shoichi ^a   Yamada, Hidehiro ^a   more..

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d ST MARIANNA UNIVERSITY   (Japan)

Author keywords

Amyopathic dermatomyositis; Anti aminoacyl transfer RNA synthetase (ARS) antibodies; Anti PL 7 antibodies; Anti Ro52 antibodies; Polymyositis dermatomyositis

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; SIGNAL RECOGNITION PARTICLE; AUTOANTIBODY; RIBONUCLEOPROTEIN; SS-A ANTIGEN;

ADULT; ARTICLE; AUTORADIOGRAPHY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE ASSOCIATION; DYSPHAGIA; ECHOCARDIOGRAPHY; ELECTRONIC MEDICAL RECORD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOSITIS; OPTICAL DENSITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMYOSITIS; PRIORITY JOURNAL; SCINTIGRAPHY; SKIN ULCER; T LYMPHOCYTE SUBPOPULATION; AGED; AUTOIMMUNE DISEASE; BLOOD; COMPLICATION; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE;

ADULT; AGED; AMINO ACYL-TRNA SYNTHETASES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DERMATOMYOSITIS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RIBONUCLEOPROTEINS;

EID: 84945232166     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2015.1091155     Document Type: Article

References (34)

1. Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000;12(6):475-81.
2. Fischer A, Swigris JJ, du Bois RM, Lynch DA, Downey GP, Cosgrove GP, et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med. 2009;103(11):1719-24.
3. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol. 2007; 19(6):523-9.
4. Mammen AL. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci. 2010;1184:134-53.
5. Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis. 2014;73(1):227-32.
6. Targoff IN, Arnett FC, Reichlin M. Antibody to threonyltransfer RNA synthetase in myositis sera. Arthritis Rheum. 1988;31(4):515-24.
7. Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum. 1996;39(9):1507-18.
8. Bernstein RM, Bunn CC, Hughes GR, Francoeur AM, Mathews MB. Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med. 1984;2(2):105-20.
9. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 1992;35(4):449-56.
10. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70(6):360-74.
11. Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, et al. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/ dermatomyositis. Arthritis Rheum. 2006;54(6):2004-9.
12. Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro/SSA autoantibody system. Autoimmun Rev. 2009;8(7):632-7.
13. Espinosa A, Zhou W, Ek M, Hedlund M, Brauner S, Popovic K, et al. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J Immunol. 2006;176(10):6277-85.
14. Rutjes SA, Vree Egberts WT, Jongen P, Van Den Hoogen F, Pruijn GJ, Van Venrooij WJ. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol. 1997;109(1):32-40.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-7.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403-7.
17. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002; 46(4):626-36.
18. Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol. 1999;11(6): 475-82.
19. Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26(10):1647-54.
20. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54(4):597-613.
21. Reeves WH, Satoh M. McAuliffe. Autoantibody testing by non-FITC methods. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of clinical laboratory immunology. 6th ed. Washington, DC: American Society of Microbiology Press; 2002:933-50.
22. Chan EK, Hamel JC, Buyon JP, Tan EM. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest. 1991;87(1):68-76.
23. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993;329(27):1993-2000.
24. Sato S, Hirakata M, Kuwana M, Nakamura K, Suwa A, Inada S, et al. Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies. Clin Exp Rheumatol. 2005;23(5):609-15.
25. Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Franceschini F, Quinzanini M, et al. Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. Arthritis Res Ther. 2012;14(2):R97.
26. Petri MH, Satoh M, Martin-Marquez BT, Vargas-Ramirez R, Jara LJ, Saavedra MA, et al. Implications in the difference of anti-Mi-2 and-p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther. 2013; 15(2):R48.
27. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54(11):3682-9.
28. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest. 1981;68(3): 611-20.
29. Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis. 2006;65(12):1635-8.
30. Hudson M, Pope J, Mahler M, Taibouet S, SteeleR Baron M. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis. Arthritis Res Ther. 2012;14(2):R50.
31. Libirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Danko K, Venkovsky J, Fisher B, et al. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore). 2012;91(4):206-11.
32. Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, et al. Comparison of long-term outcome between anti-Jo1-and anti-PL7/ PL12 positive patients with antisynthetase syndrome. Autoimmun Rev. 2012;11(10):739-45.
33. Zhang L, Wang GC, Ma Li Zu N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol. 2012;35(11):686-91.
34. Danko K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine. 2004;83(1):35-42.